These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18431051)

  • 21. Advanced glycation end products and β(2)-microglobulin as predictors of carpal tunnel syndrome in hemodialysis patients.
    Busch M; Schwenzky A; Franke S; Stein G; Wolf G
    Blood Purif; 2012; 34(1):3-9. PubMed ID: 22699860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N epsilon-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis.
    Motomiya Y; Oyama N; Iwamoto H; Uchimura T; Maruyama I
    Kidney Int; 1998 Oct; 54(4):1357-66. PubMed ID: 9767556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia.
    Ueda Y; Miyata T; Hashimoto T; Yamada H; Izuhara Y; Sakai H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Apr; 245(3):785-90. PubMed ID: 9588192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
    Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
    Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
    Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The advanced glycation endproduct pentosidine and monocyte activation in uremia.
    Friedlander MA; Witko-Sarsat V; Nguyen AT; Wu YC; Labrunte M; Verger C; Jungers P; Descamps-Latscha B
    Clin Nephrol; 1996 Jun; 45(6):379-82. PubMed ID: 8793229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac troponin T and end stage renal disease.
    Gabr AE; Ibrahim IA; Aloulou SM; Al-Alfi MA; Al-Abdlrahim KA
    Saudi Med J; 2004 Aug; 25(8):1015-9. PubMed ID: 15322590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients.
    Zoccali C; Mallamaci F; Asahia K; Benedetto FA; Tripepi G; Tripepi R; Nicocia G; Buemi M; Miyata T
    J Nephrol; 2001; 14(4):293-8. PubMed ID: 11506253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma advanced glycation end-products and skin autofluorescence are increased in COPD.
    Gopal P; Reynaert NL; Scheijen JL; Engelen L; Schalkwijk CG; Franssen FM; Wouters EF; Rutten EP
    Eur Respir J; 2014 Feb; 43(2):430-8. PubMed ID: 23645408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.
    Miyata T; van Ypersele de Strihou C; Imasawa T; Yoshino A; Ueda Y; Ogura H; Kominami K; Onogi H; Inagi R; Nangaku M; Kurokawa K
    Kidney Int; 2001 Dec; 60(6):2351-9. PubMed ID: 11737610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis.
    Fernández-Reyes MJ; Mon C; Heras M; Guevara P; Garcia MC; Sanchez R; Velasco S; Alvarez-Ude F
    J Nephrol; 2004; 17(5):721-7. PubMed ID: 15593041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low parathyroid hormone and pentosidine in hemodialysis patients.
    Panuccio V; Mallamaci F; Tripepi G; Parlongo S; Cutrupi S; Asahi K; Miyata T; Zoccali C
    Am J Kidney Dis; 2002 Oct; 40(4):810-5. PubMed ID: 12324917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of Acute Myocardial Infarction in Hemodialysis Patients With High-Sensitivity Cardiac Troponin T Assay.
    Huang HL; Zhu S; Wang WQ; Nie X; Shi YY; He Y; Song HL; Miao Q; Fu P; Wang LL; Li GX
    Arch Pathol Lab Med; 2016 Jan; 140(1):75-80. PubMed ID: 26717058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced glycation end products and mortality in hemodialysis patients.
    Schwedler SB; Metzger T; Schinzel R; Wanner C
    Kidney Int; 2002 Jul; 62(1):301-10. PubMed ID: 12081592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differences in cardiac troponin I and T levels measured in asymptomatic hemodialysis patients with last generation immunoassays].
    Deléaval P; Descombes E; Magnin JL; Martin PY; Fellay G
    Nephrol Ther; 2006 May; 2(2):75-81. PubMed ID: 16895718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients.
    Taki K; Tsuruta Y; Niwa T
    Am J Nephrol; 2007; 27(1):30-5. PubMed ID: 17215572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of the quality of diabetes control and decrease in the concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus: results from a 10 year-prospective, population-based survey on the quality of diabetes care in Germany (JEVIN).
    Schiel R; Franke S; Appel T; Voigt U; Ross IS; Kientsch-Engel R; Müller UA; Stein G
    Eur J Med Res; 2004 Aug; 9(8):391-9. PubMed ID: 15337629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of troponin T in hemodialysis patients is independent of comorbidity.
    Deegan PB; Lafferty ME; Blumsohn A; Henderson IS; McGregor E
    Kidney Int; 2001 Dec; 60(6):2399-405. PubMed ID: 11737616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.
    Gohda T; Tanimoto M; Moon JY; Gotoh H; Aoki T; Matsumoto M; Shibata T; Ohsawa I; Funabiki K; Tomino Y
    Diabetes Res Clin Pract; 2008 Aug; 81(2):196-201. PubMed ID: 18550199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.